AI Tool Outperforms PD-L1 for Predicting Lung Cancer Immunotherapy Outcomes

AI Tool Outperforms PD-L1 for Predicting Lung Cancer Immunotherapy Outcomes

An artificial intelligence system developed using data from nearly 2,400 patients with advanced non-small cell lung cancer (NSCLC) outperformed several established biomarkers for predicting outcomes following immunotherapy and improved physicians’ ability to anticipate treatment response. The findings, published in Nature Medicine, come from I³LUNG, an international effort to develop an AI-based physician decision-support system for immunotherap…

AI tool successfully predicts outcomes of immunotherapy in lung cancer

Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with immunotherapy, according to a new study published in Nature Medicine. The study reported findings from the I3LUNG project, a large international trial aimed at improving the treatment of metastatic NSCLC by developing AI-based predictive models that can help determine the best th…

New AI Tool Accurately Predicts Lung Cancer Immunotherapy Results

Artificial intelligence (AI) tools can help physicians predict treatment and survival outcomes in patients with advanced non-small cell lung cancer (NSCLC) treated with immunotherapy, according to a new study published in Nature Medicine.